Nahdi Medical Company (TADAWUL:4164)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
102.40
-1.20 (-1.16%)
Mar 24, 2026, 12:25 PM AST

Nahdi Medical Company Ratios and Metrics

Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
13,46812,35015,28817,81021,736-
Market Cap Growth
-10.84%-19.22%-14.16%-18.06%--
Enterprise Value
14,69713,51116,02517,99122,301-
Last Close Price
103.6095.00112.12125.55148.18-
PE Ratio
16.2114.8718.6319.9524.48-
Forward PE
15.3314.1217.5120.4223.26-
PS Ratio
1.321.211.622.042.52-
PB Ratio
4.914.505.917.239.69-
P/TBV Ratio
5.034.626.077.399.90-
P/FCF Ratio
18.0416.5413.2718.5115.33-
P/OCF Ratio
11.8810.8910.2513.5313.03-
PEG Ratio
3.333.076.956.593.46-
EV/Sales Ratio
1.441.321.702.072.59-
EV/EBITDA Ratio
8.7011.1214.1815.2418.71-
EV/EBIT Ratio
15.8714.5918.3818.7322.31-
EV/FCF Ratio
19.6818.1013.9118.7015.73-
Debt / Equity Ratio
0.650.650.590.480.520.85
Debt / EBITDA Ratio
1.061.060.990.760.740.93
Debt / FCF Ratio
2.392.391.331.220.821.29
Net Debt / Equity Ratio
0.450.450.220.110.040.60
Net Debt / EBITDA Ratio
1.011.010.510.230.080.90
Net Debt / FCF Ratio
1.651.650.500.280.070.91
Asset Turnover
1.591.591.641.691.871.80
Inventory Turnover
3.273.273.864.074.474.26
Quick Ratio
0.380.380.550.660.800.42
Current Ratio
1.541.541.541.691.701.40
Return on Equity (ROE)
31.17%31.17%32.51%37.93%46.16%44.13%
Return on Assets (ROA)
9.00%9.00%9.44%11.64%13.54%12.65%
Return on Invested Capital (ROIC)
23.78%25.50%29.12%35.88%38.65%35.28%
Return on Capital Employed (ROCE)
20.40%20.40%20.90%25.70%29.10%30.20%
Earnings Yield
6.17%6.73%5.37%5.01%4.08%-
FCF Yield
5.54%6.05%7.53%5.40%6.52%-
Dividend Yield
5.41%5.90%4.91%4.38%3.58%-
Payout Ratio
87.63%87.63%87.12%80.10%33.83%155.07%
Total Shareholder Return
5.41%5.90%4.91%4.38%3.58%-
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.